Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial
Open Access
- 4 May 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 390 (10089), 40-49
- https://doi.org/10.1016/s0140-6736(17)31189-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Guidelines of care for the management of psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2011
- Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trialJournal of the American Academy of Dermatology, 2011
- A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE studyBritish Journal of Dermatology, 2010
- Epidemiology and comorbidity of psoriasis in childrenBritish Journal of Dermatology, 2009
- Methotrexate treatment in 13 children with severe plaque psoriasisClinical and Experimental Dermatology, 2009
- Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)British Journal of Dermatology, 2007
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJournal of the American Academy of Dermatology, 2007
- Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core ScalesHealth and Quality of Life Outcomes, 2007
- Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension studyJournal of the American Academy of Dermatology, 2006
- Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activationAnnals Of The Rheumatic Diseases, 2002